Category: Drug Development
Drug Development market research reports by DelveInsight
-
Global Messenger RNA - Epidemiology Forecast - 2032
DelveInsight's "" Global Messenger RNA - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Global Messenger RNA epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More
-
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022
“ PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in PD-1 and PD-L1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
-
P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022
“ P38 mitogen-activated protein (MAP) kinase inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in P38 mitogen-activated protein (MAP) kinase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More
-
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022
“ Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Hematopoietic progenitor kinase 1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
TrkC receptor antagonists - Pipeline Insight, 2022
“ TrkC receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in TrkC receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2022
“ Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Trk (TrkB) receptor antagonists - Pipeline Insight, 2022
“ Trk (TrkB) receptor antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Trk (TrkB) receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032
DelveInsight's "" HER2Negative Metastatic Breast Cancer - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted HER2Negative Metastatic Breast Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More
-
5-HT2A Agonists - Pipeline Insight, 2022
“ 5-HT2A Agonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in 5-HT2A Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by p ... Read More
-
DUX4 protein inhibitors - Pipeline Insight, 2022
“ DUX4 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in DUX4 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
WEE1 protein inhibitors - Pipeline Insight, 2022
“ WEE1 protein inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in WEE1 protein inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
MPYS protein stimulants - Pipeline Insight, 2022
“ MPYS protein stimulants - Pipeline Insight, 2022 ” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in MPYS protein stimulants pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeuti ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
“ HIV integrase inhibitors - Pipeline Insight, 2021 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in HIV integrase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeut ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
DelveInsight's "" Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene and Cell Therapies targeting CNS disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spa ... Read More
-
Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022
“ Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 8+ pipeline drugs in Protein tyrosine phosphatase non receptor type 11 antagonists pipeline landscape. It covers the pipeline drug profiles, includ ... Read More
Research Assistance
